- Home
- PULM vs FEMY Comparison
PULM vs FEMY Comparison
Compare PULM & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- FEMY
- Stock Information
- Founded
- PULM 2003
- FEMY 2004
- Country
- PULM United States
- FEMY United States
- Employees
- PULM N/A
- FEMY N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- FEMY Medical/Dental Instruments
- Sector
- PULM Health Care
- FEMY Health Care
- Exchange
- PULM Nasdaq
- FEMY Nasdaq
- Market Cap
- PULM 30.9M
- FEMY N/A
- IPO Year
- PULM N/A
- FEMY 2021
- Fundamental
- Price
- PULM $6.71
- FEMY $1.25
- Analyst Decision
- PULM
- FEMY Strong Buy
- Analyst Count
- PULM 0
- FEMY 2
- Target Price
- PULM N/A
- FEMY $11.50
- AVG Volume (30 Days)
- PULM 22.2K
- FEMY 606.4K
- Earning Date
- PULM 03-21-2025
- FEMY 03-27-2025
- Dividend Yield
- PULM N/A
- FEMY N/A
- EPS Growth
- PULM N/A
- FEMY N/A
- EPS
- PULM N/A
- FEMY N/A
- Revenue
- PULM $7,806,000.00
- FEMY $1,629,108.00
- Revenue This Year
- PULM N/A
- FEMY $550.60
- Revenue Next Year
- PULM $134.88
- FEMY $76.32
- P/E Ratio
- PULM N/A
- FEMY N/A
- Revenue Growth
- PULM 6.96
- FEMY 51.97
- 52 Week Low
- PULM $1.68
- FEMY $0.86
- 52 Week High
- PULM $10.40
- FEMY $1.84
- Technical
- Relative Strength Index (RSI)
- PULM 41.18
- FEMY 35.76
- Support Level
- PULM $7.16
- FEMY $1.25
- Resistance Level
- PULM $7.33
- FEMY $1.63
- Average True Range (ATR)
- PULM 0.53
- FEMY 0.16
- MACD
- PULM -0.11
- FEMY -0.04
- Stochastic Oscillator
- PULM 0.72
- FEMY 12.05
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.